Further developments in the literature on RAAS inhibitors and COVID-19.

Further developments in the literature on RAAS inhibitors and COVID-19.
CMAJ. 2020 Jun 29;192(26):E727
Authors: Quinn KL, Fralick M, Zipursky JS, Stall NM
PMID: 32601253 [PubMed - in process]

Source: Canadian Medical Association Journal - July 1, 2020 Category: General Medicine Tags: CMAJ Source Type: research